Antineutrophil Cytoplasmic Antibody Associated Vasculitis clinical trials

Explore recruiting antineutrophil cytoplasmic antibody associated vasculitis clinical trials.

Recruiting antineutrophil cytoplasmic antibody associated vasculitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Antineutrophil Cytoplasmic Antibody Associated Vasculitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in participants With Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis

Romania, Hungary, Czechia, Poland, Denmark, France +1 more

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously Administered ALE.F02 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Renal Sparing in Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Rapidly Progressive Glomerulonephritis

Czechia, Germany, Italy, Spain, Denmark, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Antineutrophil Cytoplasmic Antibody Associated Vasculitis trials by city

Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Toronto Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Vancouver Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Montreal Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Calgary Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Edmonton Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Ottawa Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Winnipeg Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Quebec City Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Hamilton Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Kitchener Antineutrophil Cytoplasmic Antibody Associated Vasculitis in London Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Halifax Antineutrophil Cytoplasmic Antibody Associated Vasculitis in New York Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Los Angeles Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Chicago Antineutrophil Cytoplasmic Antibody Associated Vasculitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease